Although the current study did not directly demonstrate the relationship between BTLA+CD8+ T cells and resistance to anti-PD-1/PD-L1 therapy, which requires further investigation, our results suggest that tumor-infiltrating BTLA+CD8+ T cells are potentially involved in resistance to anti-PD-1/PD-L1 blockade. The gene discussed is CD8A; the disease is neoplasm.